SOCS-1 Localizes to the Microtubule Organizing Complex-Associated 20S Proteasome

REFERENCES

• Alexander, W. S. 2002. Suppressors of cytokine signalling (SOCS) in the immune system. Nat. Rev. Immunol. 2:410–416.
   PubMedGoogle Scholar
• Alexander, W. S., Starr R., Fenner J. E., Scott C. L., Handman E., Sprigg N. S., Corbin J. E., Cornish A. L., Darwiche R., Owczarek C. M., Kay T. W. H., Nicola N. A., Hertzog P. J., Metcalf D., and Hilton D. J.. 1999. SOCS1 is a critical inhibitor of interferon-γ signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98:597–608.
   PubMed Web of Science ®Google Scholar
• Andersen, J. S., Wilkinson C. J., Mayor T., Mortensen P., Nigg E. A., and Mann M.. 2003. Proteomic characterization of the human centrosome by protein correlation profiling. Nature 426:570–574.
   PubMed Web of Science ®Google Scholar
• Ben-Yair, L., Slaaby R., Herman A., Cohen Y., Biener E., Moran N., Yoshimura A., Whittaker J., Meyts P. D., Herman B., and Gertler A.. 2002. Preparation and expression of biologically active prolactin and growth hormone receptors and suppressor of cytokine signaling proteins 1, 2, 3, and 6 tagged with cyan and yellow fluorescent proteins. Protein Expr. Purif. 25:456–464.
   PubMedGoogle Scholar
• Bild, A. H., Turkson J., and Jove R.. 2002. Cytoplasmic transport of Stat3 by receptor-mediated endocytosis. EMBO J. 21:3255–3263.
   PubMedGoogle Scholar
• Chen, X. P., Losman J. A., Cowan S., Donahue E., Fay S., Vuong B. Q., Nawijn M. C., Capece D., Cohan V. L., and Rothman P.. 2002. Pim serine/threonine kinases regulate the stability of SOCS-1 protein. Proc. Natl. Acad. Sci. USA 99:2175–2180.
   PubMed Web of Science ®Google Scholar
• De Sepulveda, P., Ilangumaran S., and Rottapel R.. 2000. Suppressor of cyokine signaling-1 inhibits VAV function through protein degradation. J. Biol. Chem. 275:14005–14008.
   PubMedGoogle Scholar
• Endo, T. A., Masuhara M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui K., Matsumoto A., Tanimura S., Ohtsubo M., Misawa H., Miyazaki T., Leonor N., Taniguchi T., Fujita T., Kanakura Y., Komiya S., and Yoshimura A.. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921–924.
   PubMed Web of Science ®Google Scholar
• Frantsve, J., Schwaller J., Sternberg D. W., Kutok J., and Gilliland D. G.. 2001. SOCS-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation. Mol. Cell. Biol. 21:3547–3557.
   PubMedGoogle Scholar
• Freed, E., Lacey K. R., Huie P., Lyapina S. A., Deshaies R. J., Stearns T., and Jackson P. K.. 1999. Components of an SCF ubiquitin ligase localize to the centrosome and regulate the centrosome duplication cycle. Genes Dev. 13:2242–2257.
   PubMed Web of Science ®Google Scholar
• Glickman, M. H., and Maytal V.. 2002. Regulating the 26S proteasome. Curr. Top. Microbiol. Immunol. 268:43–72.
   PubMedGoogle Scholar
• Gstaiger, M., Marti A., and Krek W.. 1999. Association of human SCFskp2 subunit p19skp1 with interphase centrosomes and mitotic spindle poles. Exp. Cell Res. 247:554–562.
   PubMedGoogle Scholar
• Hanada, T., Yoshida T., Kinjyo I., Minoguchi S., Yasukawa H., Kato S., Mimata H., Nomura Y., Seki Y., Kubo M., and Yoshimura A.. 2001. A mutant form of JAB/SOCS1 augments the cytokine-induced JAK/STAT pathway by accelerating degradation of wild-type JAB/CIS family proteins through the SOCS-box. J. Biol. Chem. 276:40746–40754.
   PubMed Web of Science ®Google Scholar
• Hill, C. P., Masters E. I., and Whitby F. G.. 2002. The 11S regulators of 20S proteasome activity. Curr. Top. Microbiol. Immunol. 268:73–89.
   PubMedGoogle Scholar
• Jeng, R., and Stearns T.. 1999. γ-Tubulin complexes: size does matter. Trends Cell Biol. 9:339–342.
   PubMedGoogle Scholar
• Kaminzono, S., Hanada T., Yasukawa H., Minoguchi S., Kato R., Minoguchi M., Hattori K., Hatakeyama S., Yada M., Morita S., Kitamura T., Kato H., Nakayama K.-I., and Yoshimura A.. 2001. The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2. J. Biol. Chem. 276:12530–12538.
   PubMedGoogle Scholar
• Kamura, T., Burian D., Yan Q., Schmidt S. L., Lane W. S., Querido E., Branton P. E., Shilatifard A., Conaway R. C., and Conaway J. W.. 2001. MUF1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase. J. Biol. Chem. 276:29748–29753.
   PubMed Web of Science ®Google Scholar
• Kamura, T., Sato S., Haque D., Liu L., Kaelin W. G., Jr., Conaway R. C., and Conaway J. W.. 1998. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12:3872–3881.
   PubMed Web of Science ®Google Scholar
• Kamura, T., Sato S., Iwai K., Czyzyk-Krzeska M., Conaway R. C., and Conaway J. W.. 2000. Activation of HIF1a ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc. Natl. Acad. Sci. USA 97:10430–10435.
   PubMed Web of Science ®Google Scholar
• Karki, S., and Holzbaur E. L.. 1999. Cytoplasmic dynein and dynactin in cell division and intracellular transport. Curr. Opin. Cell Biol. 11:45–53.
   PubMed Web of Science ®Google Scholar
• Katzmann, D. J., Odorizzi G., and Emr S. D.. 2002. Receptor downregulation and multivesicular-body sorting. Nat. Rev. Mol. Cell Biol. 3:893–905.
   PubMed Web of Science ®Google Scholar
• Kinjyo, I., Hanada T., Inagaki-Ohara K., Mori H., Aki D., Ohishi M., Yoshida H., Kubo M., and Yoshimura A.. 2002. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17:583–591.
   PubMed Web of Science ®Google Scholar
• Koepp, D. M., Harper J. W., and Elledge S. J.. 1999. How the cyclin became a cyclin: regulated proteolysis in the cell cycle. Cell 97:431–434.
   PubMed Web of Science ®Google Scholar
• Kuriyan, J., and Cowburn D.. 1997. Modular peptide recognition domains in eukaryotic signaling. Annu. Rev. Biophys. Biomol. Struct. 26:259–288.
   PubMedGoogle Scholar
• Levkowitz, G., Waterman H., Zamir E., Kam Z., Oved S., Langdon W. Y., Beguinot L., Geiger B., and Yarden Y.. 1998. c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor. Genes Dev. 12:3663–3674.
   PubMed Web of Science ®Google Scholar
• Liu, E., Cote J. F., and Vuori K.. 2003. Negative regulation of FAK signaling by SOCS proteins. EMBO J. 22:5036–5046.
   PubMedGoogle Scholar
• Losman, J. A., Chen X. P., Hilton D., and Rothman P.. 1999. SOCS-1 is a potent inhibitor of IL-4 signal transduction. J. Immunol. 162:3770–3774.
   PubMedGoogle Scholar
• Lowin-Kropf, B., Shapiro V. S., and Weiss A.. 1998. Cytoskeletal polarization of T cells is regulated by an immunoreceptor tyrosine-based activation motif-dependent mechanism. J. Cell Biol. 140:861–871.
   PubMed Web of Science ®Google Scholar
• Mahajan, N. P., and Earp H. S.. 2003. An SH2 domain-dependent, phosphotyrosine-independent interaction between Vav1 and the Mer receptor tyrosine kinase: a mechanism for localizing guanine nucleotide-exchange factor action. J. Biol. Chem. 278:42596–42603.
   PubMedGoogle Scholar
• Marine, J.-C., Topham D. J., McKay C., Wang D., Parganas E., Stravopodis D., Yoshimura A., and Ihle J. N.. 1999. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 98:609–616.
   PubMedGoogle Scholar
• Moudjou, M., and Bornens M.. 1998. Method of centrosome isolation from cultured animal cells, p. 111–119. In Celis J. E. (ed.), Cell biology: a laboratory handbook, vol. 2. Academic Press, Inc., New York, N.Y.
   Google Scholar
• Naka, T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., Nishimoto N., Kajita T., Taga T., Yoshizaki K., Akira S., and Kishimoto T.. 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924–929.
   PubMed Web of Science ®Google Scholar
• Nakagawa, R., Naka T., Tsutsui H., Fujimoto M., Kimura A., Abe T., Seki E., Sato S., Takeuchi O., Takeda K., Akira S., Yamanishi K., Kawase I., Nakanishi K., and Kishimoto T.. 2002. SOCS-1 participates in negative regulation of LPS responses. Immunity 17:677–687.
   PubMed Web of Science ®Google Scholar
• Narazaki, M., Fujimoto M., Matsumoto T., Morita Y., Saito H., Kajita T., Yoshizaki K., Naka T., and Kishimoto T.. 1998. Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling. Proc. Natl. Acad. Sci. USA 95:13130–13134.
   PubMed Web of Science ®Google Scholar
• Nicholson, S. E., Wilson T. A., Farley A., Starr R., Zhang J.-G., Baca M., Alexander W. S., Metcalf D., Hilton D. J., and Nicola N. A.. 1999. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J. 18:375–385.
   PubMed Web of Science ®Google Scholar
• Poy, F., Yaffe M. B., Sayos J., Saxena K., Morra M., Sumegi J., Cantley L. C., Terhorst C., and Eck M. J.. 1999. Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition. Mol. Cell 4:555–561.
   PubMed Web of Science ®Google Scholar
• Rui, L., Yuan M., Frantz D., Shoelson S., and White M. F.. 2002. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J. Biol. Chem. 277:42394–42398.
   PubMed Web of Science ®Google Scholar
• Saito, H., Morita Y., Fujimoto M., Narazaki M., Naka T., and Kishimoto T.. 2000. IFN regulatory factor-1-mediated transcriptional activation of mouse STAT-induced STAT inhibitor-1 gene promoter by IFN-γ. J. Immunol. 164:5833–5843.
   PubMedGoogle Scholar
• Sasaki, A., Yasukawa H., Suzuki A., Kaminzono S., Syoda T., Kinjyo I., Sasaki M., Johnston J. A., and Yoshimura A.. 1999. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain. Genes Cells 4:339–351.
   PubMed Web of Science ®Google Scholar
• Schoenfeld, A. R., Davidowitz E. J., and Burk R. D.. 2000. Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products. Proc. Natl. Acad. Sci. USA 97:8507–8512.
   PubMed Web of Science ®Google Scholar
• Shenoy, S. K., McDonald P. H., Kohout T. A., and Lefkowitz R. J.. 2001. Regulation of receptor fate by ubiquitination of activated β2-adrenergic receptor and β-arrestin. Science 294:1307–1313.
   PubMed Web of Science ®Google Scholar
• Shtiegman, K., and Yarden Y.. 2003. The role of ubiquitylation in signaling by growth factors: implications to cancer. Semin. Cancer Biol. 13:29–40.
   PubMedGoogle Scholar
• Siewert, E., Muller-Esterl W., Starr R., Heinrich P. C., and Schaper F.. 1999. Different protein turnover of interleukin-6-type cytokine signalling components. Eur. J. Biochem. 265:251–257.
   PubMedGoogle Scholar
• Strous, G. J., and Govers R.. 1999. The ubiquitin-proteasome system and endocytosis. J. Cell Sci. 112:1417–1423.
   PubMed Web of Science ®Google Scholar
• Toniato, E., Chen X. P., Losman J., Flati V., Donahue L., and Rothman P.. 2002. TRIM8/GERP RING finger protein interacts with SOCS1. J. Biol. Chem. 277:37315–37322.
   PubMedGoogle Scholar
• Tyers, M., and Rottapel R.. 1999. VHL: a very hip ligase. Proc. Natl. Acad. Sci. USA 96:12230–12232.
   PubMed Web of Science ®Google Scholar
• Ungureanu, D., Saharinen P., Junttila I., Hilton D. J., and Silvennoinen O.. 2002. Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1. Mol. Cell. Biol. 22:3316–3326.
   PubMed Web of Science ®Google Scholar
• van Roessel, P., and Brand A. H.. 2002. Imaging into the future: visualizing gene expression and protein interactions with fluorescent proteins. Nat. Cell Biol. 4:E15-E20. [Online.]
   PubMedGoogle Scholar
• Wigley, W. C., Fabunmi R. P., Lee M. G., Marino C. R., Muallem S., DeMartino G. N., and Thomas P. J.. 1999. Dynamic association of proteasomal machinery with the centrosome. J. Cell Biol. 145:481–490.
   PubMed Web of Science ®Google Scholar
• Woodside, D. G., Obergfell A., Talapatra A., Calderwood D. A., Shattil S. J., and Ginsberg M. H.. 2002. The N-terminal SH2 domains of Syk and ZAP-70 mediate phosphotyrosine-independent binding to integrin beta cytoplasmic domains. J. Biol. Chem. 277:39401–39408.
   PubMed Web of Science ®Google Scholar
• Xia, Y., Pao G. M., Chen H.-W., Verma I. M., and Hunter T.. 2003. Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein. J. Biol. Chem. 278:5255–5263.
   PubMed Web of Science ®Google Scholar
• Yasukawa, H., Misawa H., Sakamoto H., Masuhara M., Sasaki A., Wakioka T., Ohtsuka S., Imaizumi T., Matsuda T., Ihle J. N., and Yoshimura A.. 1999. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 18:1309–1320.
   PubMed Web of Science ®Google Scholar
• Zhang, J.-G., Farley A., Nicholson S. E., Wilson T. A., Zugaro L. M., Simpson R. J., Moritz R. L., Cary D., Richardson R., Hausmann G., Kile B. J., Kent S. B. H., Alexander W. S., Metcalf D., Hilton D. J., Nicola N. A., and Baca M.. 1999. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc. Natl. Acad. Sci. USA 96:2071–2076.
   PubMed Web of Science ®Google Scholar
• Zhang, J.-G., Metcalf D., Rakar S., Asimakis M., Greenhalgh C. J., Wilson T. A., Starr R., Nicholson S. E., Carter W., Alexander W., Hilton D. J., and Nicola N. A.. 2001. The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo. Proc. Natl. Acad. Sci. USA 98:13261–13265.
   PubMed Web of Science ®Google Scholar